Page last updated: 2024-09-03

thiodigalactoside and Lymphocytopenia

thiodigalactoside has been researched along with Lymphocytopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bratman, SV; Chan, C; Diehn, M; Giaccia, AJ; Gupta, A; Koong, AC; Kuo, P; Le, QT; Loo, BW; Say, C; Shultz, DB; von Eyben, R; Wang, Z	1

Other Studies

1 other study(ies) available for thiodigalactoside and Lymphocytopenia

Article	Year
Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Nov-01, Volume: 20, Issue:21 Topics: Animals; Apoptosis; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Galectin 1; Humans; Lung Neoplasms; Lymphopenia; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Thiogalactosides	2014

Article

Year

Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Nov-01, Volume: 20, Issue:21

Topics: Animals; Apoptosis; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Galectin 1; Humans; Lung Neoplasms; Lymphopenia; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Thiogalactosides

2014